# Vikram Deshpande

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vikram-deshpande/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,008 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 114 |
| i10-index | 326 |
| Last Known Institution | Beth Israel Deaconess Medical Center |
| OpenAlex ID | https://openalex.org/A5038972103 |
| ORCID iD | https://orcid.org/0000-0003-4230-9308 |
| Works | 957 |

## Researcher papers

- [Consensus statement on the pathology of IgG4-related disease](https://scholariq.org/papers/consensus-statement-on-the-pathology-of-igg4-related-disease/)
- [Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations](https://scholariq.org/papers/recommendations-for-the-nomenclature-of-igg4-related-disease-and-its-individual/)
- [Rituximab for IgG4-related disease: a prospective, open-label trial](https://scholariq.org/papers/rituximab-for-igg4-related-disease-a-prospective-open-label-trial/)
- [IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients](https://scholariq.org/papers/igg4-related-disease-clinical-and-laboratory-features-in-one-hundred-twenty-five/)
- [Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma](https://scholariq.org/papers/polyclonal-secondary-i-fgfr2-i-mutations-drive-acquired-resistance-to-fgfr/)
- [Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations](https://scholariq.org/papers/plasmablasts-as-a-biomarker-for-igg4-related-disease-independent-of-serum-igg4/)
- [Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease](https://scholariq.org/papers/clonal-expansion-of-cd4-cytotoxic-t-lymphocytes-in-patients-with-igg4-related/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches-2/)

## Researcher university

- [Beth Israel Deaconess Medical Center](https://scholariq.org/institutions/beth-israel-deaconess-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.